Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B Cell ALL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00850057
What this trial is testing

Pharmacodynamic (PD) Study of Intranodal Adenovirus-CD154 (Ad-ISF35) in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
University of California, San Diego 16
Not applicableLooking for participantsNCT07255157
What this trial is testing

Peripheral Helper T-cells in Common Variable ImmunoDeficiency

Who this might be right for
Common Variable Immunodeficiency
University Hospital, Bordeaux 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05025800
What this trial is testing

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

Who this might be right for
Aggressive B-Cell Non-Hodgkin LymphomaAnn Arbor Stage III Grade 2 Follicular LymphomaAnn Arbor Stage III Grade 3 Follicular Lymphoma+17 more
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT02494700
What this trial is testing

Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Ann Arbor Stage I B-Cell Non-Hodgkin LymphomaAnn Arbor Stage I Grade 1 Follicular LymphomaAnn Arbor Stage I Grade 2 Follicular Lymphoma+20 more
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT00076401
What this trial is testing

Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
LeukemiaLeukemia, Lymphocytic, Chronic
Pharmacyclics LLC. 27
Testing effectiveness (Phase 2)Study completedNCT00150111
What this trial is testing

Rituximab in the Treatment of Graves' Disease

Who this might be right for
Graves´ DiseaseThyroid Associated Ophthalmopathy
Odense University Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT03615144
What this trial is testing

TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors

Who this might be right for
Non-Malignant Hematologic Disorders
Memorial Sloan Kettering Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Testing effectiveness (Phase 2)Study completedNCT01613300
What this trial is testing

Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients

Who this might be right for
B-Cell Lymphomas
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 33
Not applicableLooking for participantsNCT07782944
What this trial is testing

CD38 Targeted -PET/ CT for Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
Guilin Medical University, China 100
Very early researchUnknownNCT03895944
What this trial is testing

ET190L1-ARTEMIS™ T Cells in Relapsed, Refractory B Cell Leukemia and Lymphoma

Who this might be right for
CD19+ Lymphoma, B-CellCD19+ Leukemia, B-Cell
First Affiliated Hospital Xi'an Jiaotong University 18
Not applicableUnknownNCT06015464
What this trial is testing

An Ambispective Cohort Study of Orelabrutinib in Combination With Standard Treatment Regimen for Untreated DLBCL

Who this might be right for
Lymphoma, Large B-Cell, Diffuse Neoplasms by Histologic Type
The First Affiliated Hospital with Nanjing Medical University 81
Testing effectiveness (Phase 2)Study completedNCT00488683
What this trial is testing

B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants

Who this might be right for
Meningococcal Disease
Novartis Vaccines 216
Testing effectiveness (Phase 2)Study completedNCT00504751
What this trial is testing

Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL

Who this might be right for
Non-Hodgkin's Lymphoma
Weill Medical College of Cornell University 15
Not applicableLooking for participantsNCT07305337
What this trial is testing

Randomised Controlled Trial of Artificial Intelligence-assisted Health Education

Who this might be right for
LeukaemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaLymphoma
Zhongnan Hospital 196
Early research (Phase 1)WithdrawnNCT05263739
What this trial is testing

A First-in-Human Phase I Study of ESG206 in Subjects With B-cell Lymphoid Malignancies

Who this might be right for
B-cell Lymphoid Malignancies
Shanghai Escugen Biotechnology Co., Ltd
Testing effectiveness (Phase 2)Study completedNCT00283101
What this trial is testing

A Safety Study in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia, Lymphocytic, Chronic
Seagen Inc. 12
Post-approval studies (Phase 4)UnknownNCT04056728
What this trial is testing

A Phase IV Study to Assess the Safety of EupentaTM Inj

Who this might be right for
Hepatitis BDiphtheriaHaemophilus Influenzae Type B Infection+2 more
LG Chem 3,000
Not applicableStudy completedNCT04726995
What this trial is testing

DLBCL Treatment in Children and Adolescents

Who this might be right for
Diffuse Large B-cell Lymphoma
Sun Yat-sen University 106
Early research (Phase 1)UnknownNCT06478381
What this trial is testing

L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Lymphomas
Henan Cancer Hospital 22
Next Page